Johnson & Johnson
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 26% of the universe, above its 200-day average.
- Signal has read BUY for 4 months.
- Its last 3 Buy calls have averaged +4% over the following quarter.
- Recent price momentum is +17.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Anonymous reader poll. Unscientific, not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 255.56
- Open
- 254.43
- Day range
- 251.50 - 255.56
- Avg price
- 253.72
- Volume
- 8.85M
- Turnover
- 2.24B
- Turnover ratei
- 0.37%
- Volume ratioi
- 0.90
- Amplitudei
- 1.59%
- 52-week rangei
- 180.59 - 281.07
Valuation
- P/Ei
- 23.01
- P/E (TTM)i
- 38.57
- P/Bi
- 7.20
- EPSi
- 11.03
- Book value / shi
- 35.26
- Net profit
- 26.58B
- Net assets
- 84.97B
Share structure
- Market cap
- 611.61B
- Float capi
- 610.61B
- Shares out
- 2.41B
- Float sharesi
- 2.41B
Dividend & listing
- Div yield (TTM)i
- 2.08%
- Dividend (TTM)
- 5.28
- Listing date
- 1970-01-01
9.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-311.57M net over the window
Short interest
- Shares short
- 22.07M
- % of floati
- 0.92%
- Days to coveri
- 3.27
- As of
- 2026-09-30
Frequently asked questions
What is the current stock price of Johnson & Johnson (JNJ)?
Johnson & Johnson last traded at 253.79. The quote on this page refreshes every few seconds while US markets are open.
What is Johnson & Johnson's market cap?
About 611.61B.
What is the P/E ratio of Johnson & Johnson?
The trailing twelve-month P/E is 38.57, above its own 5-year average of 22.07 — toward the top of its historical range (100.00% percentile). See the Valuation tab for the full history.
Does Johnson & Johnson pay a dividend?
Yes. The trailing dividend yield is 2.08%. The 2025 payout was up 4.7% from 2024. See the Dividends tab for the full payment history.
Is Johnson & Johnson a buy according to analysts?
The consensus of 18 analysts is a Buy rating, with an average 12-month price target of 289.71, which implies 14.2% upside from the current price. This is not investment advice.
What is Johnson & Johnson's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Johnson & Johnson a B (Buy). Twelve-month momentum in the top 26% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-20 06:26:04 · For reference only, not investment advice and not tailored to your situation.
talc litigation headlines still spook this stock every few months but the pharma pipeline keeps quietly delivering. slow and steady, exactly how I like my healthcare names.